Lynn O'Connor Vos
Lynn is the President and CEO of the Muscular Dystrophy Association (MDA), dedicated to transforming the lives of people affected by muscular dystrophy, ALS and related neuromuscular disease. Lynn has a hands-on appreciation for patient care, and she has considerable executive experience and expertise in the fields of pharmacology, medical and clinical education and digital marketing. She is a recognized thought leader in the industry, with abundant publications in both the lay and industry press as well as numerous speaking engagements to her credit. Throughout her multifaceted career, Lynn has been a trailblazer, building powerful relationships and partnerships with institutions, providers, patients and nonprofits to truly impact healthcare.
Prior to her arrival at MDA, Lynn was the CEO of ghg | greyhealth group for nearly 23 years. While at ghg, Vos led global expansion and diversification strategies and within two years grew the company from a small, domestic professional player into an award-winning global enterprise with fully integrated, multi-channel offerings. She is the first woman to develop and run a global health communications enterprise.
Vos is currently on the board of The Jed Foundation, a leading mental health nonprofit. She was a founding board member of both The Jed Foundation and the Multiple Myeloma Research Foundation (MMRF). Vos was named Woman of the Year by the Healthcare Business Women’s Association in 2005, was nominated by the YWCA to the Academy of Women Achievers in 1999 and received the Corporate Achievement Award from The Jed Foundation in 2006. In addition to the numerous awards she has won over the years, in 2017 she was named an MM&M Healthcare Transformer and a member of the PharmaVOICE 100; in 2016, a PM360 Elite Transformational Leader and an MM&M Top 50 Health Influencer. This year she was named a PharmaVOICE Red Jacket honoree.